<DOC>
	<DOCNO>NCT01806818</DOCNO>
	<brief_summary>Multi-center Study Compare Efficacy Safety Eperisone BID TID Regimen Acute Low Back Pain Patients 7 day .</brief_summary>
	<brief_title>Comparing Efficacy Safety Between Eperisone BID TID Regimen Acute Low Back Pain Patients</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Eperisone</mesh_term>
	<criteria>Subjects ability comprehend content study participate trial willingness sign inform consent write 20≤ age ≤60 A patient symptom acute low back pain 4≤ VAS Subjects prohibit antiinflammatory drug , painkiller muscle relaxant clinical trial Chronic rheumatoid arthritis patient Patients medical history hypersensitivity Eperisone Hydrochloride Subject hereditary problem galactose intolerance , Lapp lactase deficiency , glucose galatose malabsorption Participation study 60 day first dose Female patient positive pregnancy test , lactate woman , plan pregnancy clinical trial Inadequate subject clinical trial investigator 's decision</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>